USFDA issues EIR to Strides for Bangalore facility

The USFDA visited the company's main facility between December 5 and December 9, 2022, and a form 483 with three inspectional observations was produced as a result.

165
USFDA Inspection
USFDA Inspection

Last Updated on October 9, 2024 by The Health Master

The US Food and Drug Administration (USFDA) issued an Establishment Inspection Report (EIR) in connection with the inspection of the business’s flagship facility in Bangalore, India, according to Strides Pharma Science.

The USFDA visited the company’s main facility between December 5 and December 9, 2022, and a form 483 with three inspectional observations was produced as a result.

Based on the company’s response to the observations and subsequent commitments, the USFDA has classified the outcome of this inspection as VAI (voluntary action indicated), and the EIR states that the inspection is closed.

The flagship facility of Strides in Bangalore is the largest manufacturing facility for the company, with the capability to produce finished dosage formulation products across multiple dosage formats, including tablets, capsules, ointments, creams, and liquids.

The facility services the key regulated markets of the US, Europe, and Australia.

Hyderabad is having maximum USFDA approved Pharma Units in world

USFDA gives tentative nod for Gabapentin Tablets, 300 mg and 600 mg

USFDA gives approval for Saxagliptin Tablets 2.5 mg and 5 mg

USFDA gives tentative nod for these two generic drugs

USFDA gives nod for Aflibercept injection to treat infants with prematurity issue

USFDA gives nod for generic Lenalidomide capsules

Govt taking steps to boost high value Pharmaceuticals and Medical Devices

Punjab to write to Centre Govt to regulate prices of Non Scheduled medicines

Hyderabad is having maximum USFDA approved Pharma Units in world

NLEM: Essential drugs list to be amended soon by including these products

IPA asks Govt to implement Section 42 of Pharmacy Act & Rule 65 of D&C Act

Drug alert: 67 out of 1348 samples declared as NSQ in January 2023

Cancer medicines seized from Loni found to be ‘substandard’

PCI warns of legal action against institutions not updating faculty details

New DCGI: Rajeev Raghuvanshi appointed head of apex drug regulatory body

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news